4Semana·

Furukawa Electric sold, Medley and Astroscale purchased 💴

Today I have decided to sell my position in Furukawa Electric $5801 (+9,15 %) today. The stock has risen almost 200% in the last month, mainly due to the expansion of data centers. I had originally bought the stock as they were attractively valued and have an important role in nuclear fusion with their superconductors, but until that really comes to fruition I think we can wait another 10 years+ as fusion power plants become more common. When that moment comes, Furukawa Electric will certainly play an important role.


I have now increased my positions in Medley $4480 (+2,35 %) and Astroscale $186A (+3,52 %) positions. Medley is really massively undervalued at the moment. They are one of the most important players in the digitalization of the healthcare system in Japan. They develop platforms for hospitals, doctors, pharmacies, recruiting and telemedicine. The regulatory environment suits them very well, as many of these digitalization processes will be mandatory from this year. The massive fall in the share price can be attributed to shrinking profits, which is mainly due to expansion (both within Japan and internationally). Medley is currently prioritizing growth over profitability. Nevertheless, they are well on track to achieve their medium-term targets. In my opinion, analysts are really blind about Medley. One of the most likely tenbagger candidates if you ask me.

attachment

I have also bought Astroscale. @Tenbagger2024 I recently introduced them here, feel free to take a look. They have the potential to develop into an orbital logistics group with a strong defense focus and technological moat. The risk of bankruptcy can also be classified as very low due to the strong government support and international integration.

04.03
Furukawa Elec logo
Vendido en 157,00 €
10
11 Comentarios

Imagen de perfil
Unfortunately, I can't trade Astroscale with my bank. What do you think of $2413?
1
Imagen de perfil
@Tenbagger2024 I see M3 as a grown-up version of Medley without the potential for an upward trend.
1
Imagen de perfil
@PikaPika0105 although Medley is M3's main competitor, M3 is worth 20 times more
1
Imagen de perfil
Do you know when medley earnings are?
I once had a valuation model created, base case 2027 is approx. +200% return
Imagen de perfil
@Shiya I'm assuming 30x (10 billion) by 2035. Earnings have just been announced, which caused a further decline. Profit -65%, but overall growth top (at the expense of profit). Undervalued, especially compared to M3. This is the position in my portfolio with the highest potential and minimal risk.
1
Imagen de perfil
@PikaPika0105 I'm really curious to see if you're right. I'm not invested at the moment and won't be for the time being, but I'd like to get back in at some point
Imagen de perfil
@Shiya I think €10 is a huge opportunity
Imagen de perfil
@PikaPika0105 You also said that back then at €20 😅
Imagen de perfil
@Shiya of €20 would also be 15x. It has simply become even more attractive.
Imagen de perfil
@PikaPika0105 How do you know that 30x is possible? That's an enormous amount, more than Rocket Lab
Imagen de perfil
@Shiya What kind of question is that? It's not a figure you saw in a dream, but the result of a forecast. I analyzed the company, the market growth, the industry etc. etc. and came up with the 10 billion. Bear Case 3 billion. Of course, it could all be wrong, but it's not random.
Únase a la conversación